BDNF and glaucoma: For example, BMD, commonly prescribed in clinics to reduce the IOP, was found to improve the BDNF production and preserve RGCs when administered systematically to mouse and rat models of IOP-independent glaucoma (Lee et al., 2012; Lee et al., 2010; Metoki et al., 2005).